LAVA Therapeutics NV (LVTX) Q2 2024 Earnings

21MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.51
-0.34
-0.17
0

Details

Expected EPS
-0.22
Actual EPS
-0.02
Surprise EPS
0.2
Surprise Percent
+90.91%

Description

LAVA Therapeutics NV (LVTX) has reported earnings of -0.02 per share for Q2 2024.

0 Comments

Share your thoughts